215 related articles for article (PubMed ID: 6146394)
1. Cetamolol: cardiovascular effects of a new cardioselective beta-adrenoceptor blocker possessing partial agonistic activity and lacking membrane-stabilizing activity.
Beaulieu G; Grimes D; Muirhead C; Oshiro G
Can J Physiol Pharmacol; 1984 Jun; 62(6):610-6. PubMed ID: 6146394
[TBL] [Abstract][Full Text] [Related]
2. Cardioselectivity of cetamolol compared with atenolol and nadolol.
Klausner MA; Ventura DF; Coelho J; Mullane JF; Irwin C; Hitzenberger G; Magometschnigg D; Kaik G; Garg DC; Weidler DJ
J Clin Pharmacol; 1988 Jun; 28(6):495-504. PubMed ID: 2901435
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of cetamolol and atenolol on epinephrine- and isoproterenol-induced hypokalemia in anesthetized dogs.
Klein M; Stupienski RF; Nettler S; Smith T; Oshiro G
J Cardiovasc Pharmacol; 1989 Jan; 13(1):118-24. PubMed ID: 2468922
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the beta-adrenoceptor affinity and selectivity of cetamolol, atenolol, betaxolol, and ICI-118,551.
Rimele TJ; Henry DE; Giesa FR; Buckley SK; Geiger G; Heaslip RJ; Lee DK; Grimes D
J Cardiovasc Pharmacol; 1988 Aug; 12(2):208-17. PubMed ID: 2459552
[TBL] [Abstract][Full Text] [Related]
5. Cetamolol: a new cardioselective beta-adrenoceptor blocking agent without membrane-stabilizing activity.
Beaulieu G; Jaramillo J; Cummings JR
Can J Physiol Pharmacol; 1984 Mar; 62(3):302-8. PubMed ID: 6144380
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies on cetamolol, a new potent cardioselective beta-adrenoceptor blocking agent with intrinsic sympathomimetic activity.
Grimes D; Stern M; Wojdan A; Cummings JR
Can J Physiol Pharmacol; 1983 Oct; 61(10):1109-15. PubMed ID: 6139156
[TBL] [Abstract][Full Text] [Related]
7. Cardiac and bronchial beta-adrenoceptor antagonistic potencies of atenolol, metoprolol, acebutolol, practolol, propranolol and pindolol in the anaesthetized dog.
Harms HH; Spoelstra AJ
Clin Exp Pharmacol Physiol; 1978; 5(1):53-9. PubMed ID: 25152
[TBL] [Abstract][Full Text] [Related]
8. Effects of metoprolol, alone and in combination with lidocaine, on ventricular fibrillation threshold: comparison with atenolol, propranolol, and pindolol.
Coram WM; Olson RW; Beil ME; Cabot CF; Weiss GB
J Cardiovasc Pharmacol; 1987 May; 9(5):611-21. PubMed ID: 2439844
[TBL] [Abstract][Full Text] [Related]
9. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
Ishibashi T; Mitomi A; Tatebe S; Imai S
Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the acute effects of cetamolol (AI-27,303), atenolol, propranolol, and dexpropranolol on blood pressure, sympathetic nerve and ganglion activity of cats.
Jaramillo J
Can J Physiol Pharmacol; 1983 Jul; 61(7):693-8. PubMed ID: 6137273
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man.
McCaffrey PM; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):571-80. PubMed ID: 2893634
[TBL] [Abstract][Full Text] [Related]
13. Beta-blocking action of bopindolol, a new beta-blocker, and its active metabolites in open chest dogs.
Okuhira M; Nakazawa M; Kameda H; Hara K; Kawada T; Imai S
Arch Int Pharmacodyn Ther; 1993; 323():5-15. PubMed ID: 7902696
[TBL] [Abstract][Full Text] [Related]
14. Beta-adrenoceptor blockade by atenolol, metoprolol and propranolol in the anaesthetized cat.
Lundgren B; Carlsson E; Herrmann I
Eur J Pharmacol; 1979 May; 55(3):263-8. PubMed ID: 37096
[TBL] [Abstract][Full Text] [Related]
15. [The effect of atenolol on the cardiovascular system (author's transl)].
Izumi T; Nishimura T; Sakai K; Abiko Y; Hattori Y; Nakaya H; Kanno M
Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):505-13. PubMed ID: 6110622
[TBL] [Abstract][Full Text] [Related]
16. Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
Ono H; Kanazawa Y; O'Hara N; Hashimoto K
Jpn J Pharmacol; 1984 Dec; 36(4):507-17. PubMed ID: 6151997
[TBL] [Abstract][Full Text] [Related]
17. Cardiac and renovascular effects in the anaesthetized dog of BW A575C: a novel angiotensin converting enzyme inhibitor with beta-adrenoceptor blocking properties.
Cambridge D; Whiting MV; Allan G
Br J Pharmacol; 1988 Jan; 93(1):165-75. PubMed ID: 2894874
[TBL] [Abstract][Full Text] [Related]
18. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
[TBL] [Abstract][Full Text] [Related]
19. The additional properties of beta adrenoceptor blocking drugs.
Prichard BN; Tomlinson B
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
[TBL] [Abstract][Full Text] [Related]
20. The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.
Blaber LC; Burden DT; Eigenmann R; Gerold M
J Cardiovasc Pharmacol; 1984; 6(1):165-75. PubMed ID: 6199600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
